APO Research
Talk to an analyst

APO RESEARCH · REPORT

PCR-based Mycoplasma Testing Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global PCR-based Mycoplasma Testing Service Industry Growth and Trends Forecast to 2032

3 July 2026110 pages

Choose your research edition.

Industry ResearchPCR-based Mycoplasma Testing Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal PCR-based Mycoplasma Testing Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal PCR-based Mycoplasma Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PCR-based Mycoplasma Testing Service Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal PCR-based Mycoplasma Testing Service Market Analysis and Forecast 2026-2032185 pages · $4,950 USD

Market perspective

According to APO Research, the global PCR-based Mycoplasma Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for PCR-based Mycoplasma Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for PCR-based Mycoplasma Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PCR-based Mycoplasma Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the PCR-based Mycoplasma Testing Service market include Charles River Laboratories International, Thermo Fisher Scientific, SGS, Bionique Testing Laboratories, WuXi AppTec, Labcorp, IDEXX BioAnalytics, WiCell and Creative Biogene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global PCR-based Mycoplasma Testing Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The PCR-based Mycoplasma Testing Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global PCR-based Mycoplasma Testing Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to PCR-based Mycoplasma Testing Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global PCR-based Mycoplasma Testing Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

PCR-based Mycoplasma Testing Service Market by Company

Charles River Laboratories International

Thermo Fisher Scientific

SGS

Bionique Testing Laboratories

WuXi AppTec

Labcorp

IDEXX BioAnalytics

WiCell

Creative Biogene

Eurofins Scientific

Hylabs

JOINN Laboratories

Shimadzu Diagnostics

CellSafe

FullHope Biomedical

Syngene International

Beyotime

CTI Cert

Shenke Bio

PCR-based Mycoplasma Testing Service Segment by Type

Product Release Testing

Contamination Investigation Testing

Regulatory Compliance Testing

Others

PCR-based Mycoplasma Testing Service Segment by Application

Biopharmaceutical Companies

Contract Research/Manufacturing Organizations (CROs/CMOs)

Universities and Research Institutions

Others

PCR-based Mycoplasma Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PCR-based Mycoplasma Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PCR-based Mycoplasma Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PCR-based Mycoplasma Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of PCR-based Mycoplasma Testing Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global PCR-based Mycoplasma Testing Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global PCR-based Mycoplasma Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global PCR-based Mycoplasma Testing Service Market Share by Region (2021-2026) Table 4. Global PCR-based Mycoplasma Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global PCR-based Mycoplasma Testing Service Market Share by Region (2027-2032) Table 6. Global PCR-based Mycoplasma Testing Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global PCR-based Mycoplasma Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global PCR-based Mycoplasma Testing Service Market Size Share by Type (2021-2026) Table 9. Global PCR-based Mycoplasma Testing Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global PCR-based Mycoplasma Testing Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global PCR-based Mycoplasma Testing Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global PCR-based Mycoplasma Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global PCR-based Mycoplasma Testing Service Market Size Share by Application (2021-2026) Table 24. Global PCR-based Mycoplasma Testing Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global PCR-based Mycoplasma Testing Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. PCR-based Mycoplasma Testing Service Industry Trends Table 37. PCR-based Mycoplasma Testing Service Industry Drivers Table 38. PCR-based Mycoplasma Testing Service Industry Opportunities and Challenges Table 39. PCR-based Mycoplasma Testing Service Industry Restraints Table 40. Global PCR-based Mycoplasma Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global PCR-based Mycoplasma Testing Service Revenue Market Share by Company (2021-2026) Table 42. Global PCR-based Mycoplasma Testing Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global PCR-based Mycoplasma Testing Service Key Company Headquarters & Area Served Table 44. Global PCR-based Mycoplasma Testing Service Company, Product Type & Application Table 45. Global PCR-based Mycoplasma Testing Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global PCR-based Mycoplasma Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Charles River Laboratories International Company Information Table 49. Charles River Laboratories International Business Overview Table 50. Charles River Laboratories International PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Charles River Laboratories International PCR-based Mycoplasma Testing Service Product Portfolio Table 52. Charles River Laboratories International Recent Development Table 53. Thermo Fisher Scientific Company Information Table 54. Thermo Fisher Scientific Business Overview Table 55. Thermo Fisher Scientific PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Thermo Fisher Scientific PCR-based Mycoplasma Testing Service Product Portfolio Table 57. Thermo Fisher Scientific Recent Development Table 58. SGS Company Information Table 59. SGS Business Overview Table 60. SGS PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. SGS PCR-based Mycoplasma Testing Service Product Portfolio Table 62. SGS Recent Development Table 63. Bionique Testing Laboratories Company Information Table 64. Bionique Testing Laboratories Business Overview Table 65. Bionique Testing Laboratories PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Bionique Testing Laboratories PCR-based Mycoplasma Testing Service Product Portfolio Table 67. Bionique Testing Laboratories Recent Development Table 68. WuXi AppTec Company Information Table 69. WuXi AppTec Business Overview Table 70. WuXi AppTec PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. WuXi AppTec PCR-based Mycoplasma Testing Service Product Portfolio Table 72. WuXi AppTec Recent Development Table 73. Labcorp Company Information Table 74. Labcorp Business Overview Table 75. Labcorp PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Labcorp PCR-based Mycoplasma Testing Service Product Portfolio Table 77. Labcorp Recent Development Table 78. IDEXX BioAnalytics Company Information Table 79. IDEXX BioAnalytics Business Overview Table 80. IDEXX BioAnalytics PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. IDEXX BioAnalytics PCR-based Mycoplasma Testing Service Product Portfolio Table 82. IDEXX BioAnalytics Recent Development Table 83. WiCell Company Information Table 84. WiCell Business Overview Table 85. WiCell PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. WiCell PCR-based Mycoplasma Testing Service Product Portfolio Table 87. WiCell Recent Development Table 88. Creative Biogene Company Information Table 89. Creative Biogene Business Overview Table 90. Creative Biogene PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Creative Biogene PCR-based Mycoplasma Testing Service Product Portfolio Table 92. Creative Biogene Recent Development Table 93. Eurofins Scientific Company Information Table 94. Eurofins Scientific Business Overview Table 95. Eurofins Scientific PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Eurofins Scientific PCR-based Mycoplasma Testing Service Product Portfolio Table 97. Eurofins Scientific Recent Development Table 98. Hylabs Company Information Table 99. Hylabs Business Overview Table 100. Hylabs PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Hylabs PCR-based Mycoplasma Testing Service Product Portfolio Table 102. Hylabs Recent Development Table 103. JOINN Laboratories Company Information Table 104. JOINN Laboratories Business Overview Table 105. JOINN Laboratories PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. JOINN Laboratories PCR-based Mycoplasma Testing Service Product Portfolio Table 107. JOINN Laboratories Recent Development Table 108. Shimadzu Diagnostics Company Information Table 109. Shimadzu Diagnostics Business Overview Table 110. Shimadzu Diagnostics PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Shimadzu Diagnostics PCR-based Mycoplasma Testing Service Product Portfolio Table 112. Shimadzu Diagnostics Recent Development Table 113. CellSafe Company Information Table 114. CellSafe Business Overview Table 115. CellSafe PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. CellSafe PCR-based Mycoplasma Testing Service Product Portfolio Table 117. CellSafe Recent Development Table 118. FullHope Biomedical Company Information Table 119. FullHope Biomedical Business Overview Table 120. FullHope Biomedical PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. FullHope Biomedical PCR-based Mycoplasma Testing Service Product Portfolio Table 122. FullHope Biomedical Recent Development Table 123. Syngene International Company Information Table 124. Syngene International Business Overview Table 125. Syngene International PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Syngene International PCR-based Mycoplasma Testing Service Product Portfolio Table 127. Syngene International Recent Development Table 128. Beyotime Company Information Table 129. Beyotime Business Overview Table 130. Beyotime PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Beyotime PCR-based Mycoplasma Testing Service Product Portfolio Table 132. Beyotime Recent Development Table 133. CTI Cert Company Information Table 134. CTI Cert Business Overview Table 135. CTI Cert PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. CTI Cert PCR-based Mycoplasma Testing Service Product Portfolio Table 137. CTI Cert Recent Development Table 138. Shenke Bio Company Information Table 139. Shenke Bio Business Overview Table 140. Shenke Bio PCR-based Mycoplasma Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Shenke Bio PCR-based Mycoplasma Testing Service Product Portfolio Table 142. Shenke Bio Recent Development Table 143. North America PCR-based Mycoplasma Testing Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America PCR-based Mycoplasma Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 145. North America PCR-based Mycoplasma Testing Service Market Share by Country (2021-2026) Table 146. North America PCR-based Mycoplasma Testing Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America PCR-based Mycoplasma Testing Service Market Share Forecast by Country (2027-2032) Table 148. Europe PCR-based Mycoplasma Testing Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe PCR-based Mycoplasma Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe PCR-based Mycoplasma Testing Service Market Share by Country (2021-2026) Table 151. Europe PCR-based Mycoplasma Testing Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe PCR-based Mycoplasma Testing Service Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific PCR-based Mycoplasma Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific PCR-based Mycoplasma Testing Service Market Share by Country (2021-2026) Table 156. Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific PCR-based Mycoplasma Testing Service Market Share Forecast by Country (2027-2032) Table 158. Latin America PCR-based Mycoplasma Testing Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America PCR-based Mycoplasma Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America PCR-based Mycoplasma Testing Service Market Share by Country (2021-2026) Table 161. Latin America PCR-based Mycoplasma Testing Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America PCR-based Mycoplasma Testing Service Market Share Forecast by Country (2027-2032) Table 163. Middle East & Africa PCR-based Mycoplasma Testing Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East & Africa PCR-based Mycoplasma Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East & Africa PCR-based Mycoplasma Testing Service Market Share by Country (2021-2026) Table 166. Middle East & Africa PCR-based Mycoplasma Testing Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East & Africa PCR-based Mycoplasma Testing Service Market Share Forecast by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. PCR-based Mycoplasma Testing Service Product Image Figure 3. Global PCR-based Mycoplasma Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global PCR-based Mycoplasma Testing Service Market Size (2021-2032) & (US$ Million) Figure 5. Global PCR-based Mycoplasma Testing Service Market Share by Region: 2025 VS 2032 Figure 6. Global PCR-based Mycoplasma Testing Service Market Share by Region (2021-2032) Figure 7. North America PCR-based Mycoplasma Testing Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe PCR-based Mycoplasma Testing Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America PCR-based Mycoplasma Testing Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa PCR-based Mycoplasma Testing Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Product Release Testing Image Figure 13. Global Product Release Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Contamination Investigation Testing Image Figure 15. Global Contamination Investigation Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Regulatory Compliance Testing Image Figure 17. Global Regulatory Compliance Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global PCR-based Mycoplasma Testing Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global PCR-based Mycoplasma Testing Service Market Share by Type 2025 VS 2032 Figure 22. North America PCR-based Mycoplasma Testing Service Market Size Share by Type (2021-2032) Figure 23. Europe PCR-based Mycoplasma Testing Service Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Share by Type (2021-2032) Figure 25. Latin America PCR-based Mycoplasma Testing Service Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa PCR-based Mycoplasma Testing Service Market Size Share by Type (2021-2032) Figure 27. Biopharmaceutical Companies Image Figure 28. Global Biopharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Contract Research/Manufacturing Organizations (CROs/CMOs) Image Figure 30. Global Contract Research/Manufacturing Organizations (CROs/CMOs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Universities and Research Institutions Image Figure 32. Global Universities and Research Institutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global PCR-based Mycoplasma Testing Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global PCR-based Mycoplasma Testing Service Market Share by Application 2025 VS 2032 Figure 37. North America PCR-based Mycoplasma Testing Service Market Size Share by Application (2021-2032) Figure 38. Europe PCR-based Mycoplasma Testing Service Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Share by Application (2021-2032) Figure 40. Latin America PCR-based Mycoplasma Testing Service Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa PCR-based Mycoplasma Testing Service Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 PCR-based Mycoplasma Testing Service Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America PCR-based Mycoplasma Testing Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America PCR-based Mycoplasma Testing Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America PCR-based Mycoplasma Testing Service Market Share by Country (2021-2032) Figure 47. Europe PCR-based Mycoplasma Testing Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe PCR-based Mycoplasma Testing Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe PCR-based Mycoplasma Testing Service Market Share by Country (2021-2032) Figure 50. Asia-Pacific PCR-based Mycoplasma Testing Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific PCR-based Mycoplasma Testing Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific PCR-based Mycoplasma Testing Service Market Share by Country (2021-2032) Figure 53. Latin America PCR-based Mycoplasma Testing Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America PCR-based Mycoplasma Testing Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America PCR-based Mycoplasma Testing Service Market Share by Country (2021-2032) Figure 56. Middle East & Africa PCR-based Mycoplasma Testing Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa PCR-based Mycoplasma Testing Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa PCR-based Mycoplasma Testing Service Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Product Release Testing
  • Contamination Investigation Testing
  • Regulatory Compliance Testing
  • Others
Applications
  • Biopharmaceutical Companies
  • Contract Research/Manufacturing Organizations (CROs/CMOs)
  • Universities and Research Institutions
  • Others
Companies covered
  • Charles River Laboratories International
  • Thermo Fisher Scientific
  • SGS
  • Bionique Testing Laboratories
  • WuXi AppTec
  • Labcorp
  • IDEXX BioAnalytics
  • WiCell
  • Creative Biogene
  • Eurofins Scientific
  • Hylabs
  • JOINN Laboratories
  • Shimadzu Diagnostics
  • CellSafe
  • FullHope Biomedical
  • Syngene International
  • Beyotime
  • CTI Cert
  • Shenke Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global PCR-based Mycoplasma Testing Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global PCR-based Mycoplasma Testing Service Market Size by Region (2021-2032)
  5. 1.4.1 Global PCR-based Mycoplasma Testing Service Market Size by Region (2021-2026)
  6. 1.4.2 Global PCR-based Mycoplasma Testing Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions PCR-based Mycoplasma Testing Service Market Size (2021-2032)
  8. 1.5.1 North America PCR-based Mycoplasma Testing Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe PCR-based Mycoplasma Testing Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America PCR-based Mycoplasma Testing Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa PCR-based Mycoplasma Testing Service Market Size Growth Rate (2021-2032)
2 PCR-based Mycoplasma Testing Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Product Release Testing
  3. 2.1.2 Contamination Investigation Testing
  4. 2.1.3 Regulatory Compliance Testing
  5. 2.1.4 Others
  6. 2.2 Global PCR-based Mycoplasma Testing Service Market Size by Type
  7. 2.2.1 Global PCR-based Mycoplasma Testing Service Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global PCR-based Mycoplasma Testing Service Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global PCR-based Mycoplasma Testing Service Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global PCR-based Mycoplasma Testing Service Market Size by Regions
  11. 2.3.1 North America PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa PCR-based Mycoplasma Testing Service Market Size Breakdown by Type (2021-2026)
3 PCR-based Mycoplasma Testing Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Biopharmaceutical Companies
  3. 3.1.2 Contract Research/Manufacturing Organizations (CROs/CMOs)
  4. 3.1.3 Universities and Research Institutions
  5. 3.1.4 Others
  6. 3.2 Global PCR-based Mycoplasma Testing Service Market Size by Application
  7. 3.2.1 Global PCR-based Mycoplasma Testing Service Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global PCR-based Mycoplasma Testing Service Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global PCR-based Mycoplasma Testing Service Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global PCR-based Mycoplasma Testing Service Market Size by Regions
  11. 3.3.1 North America PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa PCR-based Mycoplasma Testing Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 PCR-based Mycoplasma Testing Service Industry Trends
  2. 4.2 PCR-based Mycoplasma Testing Service Industry Drivers
  3. 4.3 PCR-based Mycoplasma Testing Service Industry Opportunities and Challenges
  4. 4.4 PCR-based Mycoplasma Testing Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by PCR-based Mycoplasma Testing Service Revenue (2021-2026)
  2. 5.2 Global PCR-based Mycoplasma Testing Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global PCR-based Mycoplasma Testing Service Key Company Headquarters & Area Served
  4. 5.4 Global PCR-based Mycoplasma Testing Service Company, Product Type & Application
  5. 5.5 Global PCR-based Mycoplasma Testing Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global PCR-based Mycoplasma Testing Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 PCR-based Mycoplasma Testing Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 PCR-based Mycoplasma Testing Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Charles River Laboratories International
  2. 6.1.1 Charles River Laboratories International Company Information
  3. 6.1.2 Charles River Laboratories International Business Overview
  4. 6.1.3 Charles River Laboratories International PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Charles River Laboratories International PCR-based Mycoplasma Testing Service Product Portfolio
  6. 6.1.5 Charles River Laboratories International Recent Developments
  7. 6.2 Thermo Fisher Scientific
  8. 6.2.1 Thermo Fisher Scientific Company Information
  9. 6.2.2 Thermo Fisher Scientific Business Overview
  10. 6.2.3 Thermo Fisher Scientific PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Thermo Fisher Scientific PCR-based Mycoplasma Testing Service Product Portfolio
  12. 6.2.5 Thermo Fisher Scientific Recent Developments
  13. 6.3 SGS
  14. 6.3.1 SGS Company Information
  15. 6.3.2 SGS Business Overview
  16. 6.3.3 SGS PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 SGS PCR-based Mycoplasma Testing Service Product Portfolio
  18. 6.3.5 SGS Recent Developments
  19. 6.4 Bionique Testing Laboratories
  20. 6.4.1 Bionique Testing Laboratories Company Information
  21. 6.4.2 Bionique Testing Laboratories Business Overview
  22. 6.4.3 Bionique Testing Laboratories PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Bionique Testing Laboratories PCR-based Mycoplasma Testing Service Product Portfolio
  24. 6.4.5 Bionique Testing Laboratories Recent Developments
  25. 6.5 WuXi AppTec
  26. 6.5.1 WuXi AppTec Company Information
  27. 6.5.2 WuXi AppTec Business Overview
  28. 6.5.3 WuXi AppTec PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 WuXi AppTec PCR-based Mycoplasma Testing Service Product Portfolio
  30. 6.5.5 WuXi AppTec Recent Developments
  31. 6.6 Labcorp
  32. 6.6.1 Labcorp Company Information
  33. 6.6.2 Labcorp Business Overview
  34. 6.6.3 Labcorp PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Labcorp PCR-based Mycoplasma Testing Service Product Portfolio
  36. 6.6.5 Labcorp Recent Developments
  37. 6.7 IDEXX BioAnalytics
  38. 6.7.1 IDEXX BioAnalytics Company Information
  39. 6.7.2 IDEXX BioAnalytics Business Overview
  40. 6.7.3 IDEXX BioAnalytics PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 IDEXX BioAnalytics PCR-based Mycoplasma Testing Service Product Portfolio
  42. 6.7.5 IDEXX BioAnalytics Recent Developments
  43. 6.8 WiCell
  44. 6.8.1 WiCell Company Information
  45. 6.8.2 WiCell Business Overview
  46. 6.8.3 WiCell PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 WiCell PCR-based Mycoplasma Testing Service Product Portfolio
  48. 6.8.5 WiCell Recent Developments
  49. 6.9 Creative Biogene
  50. 6.9.1 Creative Biogene Company Information
  51. 6.9.2 Creative Biogene Business Overview
  52. 6.9.3 Creative Biogene PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Creative Biogene PCR-based Mycoplasma Testing Service Product Portfolio
  54. 6.9.5 Creative Biogene Recent Developments
  55. 6.10 Eurofins Scientific
  56. 6.10.1 Eurofins Scientific Company Information
  57. 6.10.2 Eurofins Scientific Business Overview
  58. 6.10.3 Eurofins Scientific PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Eurofins Scientific PCR-based Mycoplasma Testing Service Product Portfolio
  60. 6.10.5 Eurofins Scientific Recent Developments
  61. 6.11 Hylabs
  62. 6.11.1 Hylabs Company Information
  63. 6.11.2 Hylabs Business Overview
  64. 6.11.3 Hylabs PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Hylabs PCR-based Mycoplasma Testing Service Product Portfolio
  66. 6.11.5 Hylabs Recent Developments
  67. 6.12 JOINN Laboratories
  68. 6.12.1 JOINN Laboratories Company Information
  69. 6.12.2 JOINN Laboratories Business Overview
  70. 6.12.3 JOINN Laboratories PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 JOINN Laboratories PCR-based Mycoplasma Testing Service Product Portfolio
  72. 6.12.5 JOINN Laboratories Recent Developments
  73. 6.13 Shimadzu Diagnostics
  74. 6.13.1 Shimadzu Diagnostics Company Information
  75. 6.13.2 Shimadzu Diagnostics Business Overview
  76. 6.13.3 Shimadzu Diagnostics PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Shimadzu Diagnostics PCR-based Mycoplasma Testing Service Product Portfolio
  78. 6.13.5 Shimadzu Diagnostics Recent Developments
  79. 6.14 CellSafe
  80. 6.14.1 CellSafe Company Information
  81. 6.14.2 CellSafe Business Overview
  82. 6.14.3 CellSafe PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 CellSafe PCR-based Mycoplasma Testing Service Product Portfolio
  84. 6.14.5 CellSafe Recent Developments
  85. 6.15 FullHope Biomedical
  86. 6.15.1 FullHope Biomedical Company Information
  87. 6.15.2 FullHope Biomedical Business Overview
  88. 6.15.3 FullHope Biomedical PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 FullHope Biomedical PCR-based Mycoplasma Testing Service Product Portfolio
  90. 6.15.5 FullHope Biomedical Recent Developments
  91. 6.16 Syngene International
  92. 6.16.1 Syngene International Company Information
  93. 6.16.2 Syngene International Business Overview
  94. 6.16.3 Syngene International PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Syngene International PCR-based Mycoplasma Testing Service Product Portfolio
  96. 6.16.5 Syngene International Recent Developments
  97. 6.17 Beyotime
  98. 6.17.1 Beyotime Company Information
  99. 6.17.2 Beyotime Business Overview
  100. 6.17.3 Beyotime PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Beyotime PCR-based Mycoplasma Testing Service Product Portfolio
  102. 6.17.5 Beyotime Recent Developments
  103. 6.18 CTI Cert
  104. 6.18.1 CTI Cert Company Information
  105. 6.18.2 CTI Cert Business Overview
  106. 6.18.3 CTI Cert PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 CTI Cert PCR-based Mycoplasma Testing Service Product Portfolio
  108. 6.18.5 CTI Cert Recent Developments
  109. 6.19 Shenke Bio
  110. 6.19.1 Shenke Bio Company Information
  111. 6.19.2 Shenke Bio Business Overview
  112. 6.19.3 Shenke Bio PCR-based Mycoplasma Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Shenke Bio PCR-based Mycoplasma Testing Service Product Portfolio
  114. 6.19.5 Shenke Bio Recent Developments
7 North America
  1. 7.1 North America PCR-based Mycoplasma Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America PCR-based Mycoplasma Testing Service Market Size by Country (2021-2026)
  3. 7.3 North America PCR-based Mycoplasma Testing Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe PCR-based Mycoplasma Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe PCR-based Mycoplasma Testing Service Market Size by Country (2021-2026)
  3. 8.3 Europe PCR-based Mycoplasma Testing Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific PCR-based Mycoplasma Testing Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific PCR-based Mycoplasma Testing Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America PCR-based Mycoplasma Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America PCR-based Mycoplasma Testing Service Market Size by Country (2021-2026)
  3. 10.3 South America PCR-based Mycoplasma Testing Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa PCR-based Mycoplasma Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa PCR-based Mycoplasma Testing Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa PCR-based Mycoplasma Testing Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst